Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Drilling at Pt. Leamington unveils a copper-rich extension, targeting near-surface high-grade zones (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Breaking & Recent News InnoCan Pharma Corporation C.INNO

Alternate Symbol(s):  INNPF

Healthcare Drug Manufacturers - Specialty & Generic
InnoCan Pharma Corporation, a pharmaceutical technology company, focuses on the development of various drug delivery platforms combining cannabidiol (CBD) with other pharmaceutical ingredients in the United States, Canada, Europe, and internationally. The company operates in two segments: Online Sales and Other Operations. It engages in the research and development of CBD loaded exosomes, as... see more

Recent & Breaking News (CSE:INNO)

Innocan Pharma to participate in the White Label World Expo on February 27-28th, 2024

Canada NewsWire February 20, 2024

Innocan Pharma to provide a corporate update via Zoom livestream on February 12, 2024, at 4:00pm EST

Canada NewsWire February 5, 2024

Innocan Pharma Announces Expert Team for LPT CBD Application to United States Food and Drug Administration

Canada NewsWire December 12, 2023

Innocan Pharma Announces Promising LPT-CBD Safety Indications -Implications from a prolong use in animals

Canada NewsWire November 3, 2023

Innocan Pharma reports a groundbreaking discovery regarding its LPD platform and global CBD research

Canada NewsWire October 23, 2023

Innocan Pharma Announces Closing of Second and Final Tranche of Financing

Canada NewsWire October 20, 2023

Innocan Pharma Announces Closing of First Tranche Private Placement and Provides Corporate Update

Canada NewsWire October 12, 2023

Innocan Pharma Announces Brokered LIFE Offering of Units for Up to $3 Million

GlobeNewswire September 21, 2023

Innocan Pharma Announces the Addition of Dr. Joseph V. Pergolizzi, Jr., M.D. to its Advisory Board

Canada NewsWire September 15, 2023

Innocan Pharma Announces Promising Results from Hair Care Cream Efficacy Test

Canada NewsWire September 5, 2023

Innocan Pharma Announces Clinical Study Results: Evidence of Reduced Osteoarthritis Pain in Dogs After Liposomal CBD Injection

Canada NewsWire August 29, 2023

Innocan Pharma Reports Q2 2023 Results Including US$2.706M Increase in Revenues Compared to Q2, 2022

Canada NewsWire August 25, 2023

Innocan Pharma Announces Promising Successful Results in Efficacy Trial of Diabetic Foot Relief Treatment

Canada NewsWire August 15, 2023

Innocan Pharma Announces Closing of Private Placement

Canada NewsWire August 4, 2023

Innocan Pharma Unveils Groundbreaking Veterinary Breakthroughs at EAVPT 2023 Congress

Canada NewsWire June 22, 2023

Innocan Pharma Reports Q1 2023 Results including US$1.3M Increase in Revenues Compared to Q1 2022

Canada NewsWire May 31, 2023

Innocan Pharma Reports Success in a Pre-Clinical Trial of a Liposomal-CBD Injection on a Paralyzed Goat

Canada NewsWire May 8, 2023

Innocan Pharma Announces 5000 Units Sale and Expansion to Lithuania, Latvia & Estonia Markets

Canada NewsWire May 1, 2023

Innocan Pharma Reports Annual 2022 Results with USD 2.6M in Revenue

Canada NewsWire April 18, 2023

Innocan Reports Novel Cannabinoid Delivery Platform Patent Application

Canada NewsWire April 3, 2023

Podcasts